Skip to main content
UniHealth

Doctor search

Jaswant Singh Basraon, DO

Cardiovascular Disease (Cardiology) · Fresno

NPI 1720283393

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
6
Since medical school
20 years
Graduated 2006

Offices

6 locations · Community Foundation Medical Group · Fresno Community Hospital and Medical Center

Looking this up.

Hospitals listed: Clovis Community Medical Center · Community Regional Medical Center · Saint Agnes Medical Center. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Basraon’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence G11348 · Cancelled

Licence status: Cancelled · since 1965 · State University of New York at Buffalo School of Medicine.

License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.

Matched on the licence number without its letter prefix; check the name before relying on it.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

State licence records

2 licences

  • Texas N6161Physician License · since 2010 · expires 2019-11-30
    Canc Non-RenewalNo board action on this licenceCheck it with the state
  • Texas BP10026266Physician-in-Training Permit · since 2006 · expires 2009-06-30
    Permit TerminatedNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

Hospitals they work in

3 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Clovis Community Medical CenterClovis, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 80% would definitely recommend it
    Overall rating: 2 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.7 (12.1 to 17.7) · 421 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.692, Oct 2024 – Sep 2025
  • Community Regional Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend it
    Overall rating: 1 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 211.21 (174.88 to 247.54) · 239 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.705, Oct 2024 – Sep 2025
  • Saint Agnes Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Trinity Health, which runs 105 hospitals in 16 statesPatients rate it 3 of 5 · 76% would definitely recommend it
    Overall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.312, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.141, Oct 2024 – Sep 2025
See every measure and the patient survey for Clovis Community Medical Center

Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 0 better, 6 the same, 1 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Clovis Community Medical Center
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.7 (12.1 to 17.7) · 421 casesWorseJan 2024 – Dec 2024
Clostridium Difficile (C.Diff)Infections0.692BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.97 (0.04 to 1.89) · 1,840 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.16 (0.86 to 1.45)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths217.06 (167.45 to 266.67) · 84 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.4 · 69 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths9.1 · 165 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths13.4 · 161 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths14 · 507 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths17.6 · 798 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 336 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.1 · 3,771 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.19 (0 to 0.39) · 8,649 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.27 (0.08 to 0.46) · 9,146 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.46 (1.47 to 5.45) · 1,654 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths2.19 (0.61 to 3.78) · 387 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.18 (0.7 to 3.66) · 1,578 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths13.47 (7.08 to 19.87) · 374 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.99 (1.37 to 8.61) · 379 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.58 (0.13 to 3.04) · 405 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.8 (0.23 to 1.38) · 8,198 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.2 · 90 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.651No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.922No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.449No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.509No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.3 · 210 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits23 · 702 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-1.5 · 152 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits58.4 · 556 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits18 · 769 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits17.8 · 802 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.5 (4 to 7.4) · 421 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.2 · 91 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 93 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20 · 200 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.8 to 15.6) · 2,398 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.6 to 1.1) · 720 casesNo differentJan 2024 – Dec 2024

What patients said (441 patients answered, 26% of those asked)

Patient survey stars by topic at Clovis Community Medical Center
Cleanliness4
Nurse communication3
Doctor communication2
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Clovis Community Medical Center
Room was "always" clean80%
Nurses "always" communicated well75%
Doctors "always" communicated well75%
Staff "always" explained61%
Yes, staff "did" give patients this information87%
Yes, staff "did" give patients information about help after discharge85%
Doctors "always" explained things so they could understand69%
Doctors "always" listened carefully73%
Doctors "always" treated them with courtesy and respect84%
Patients who gave a rating of "9" or "10" (high)72%
Staff "always" explained new medications74%
Nurses "always" explained things so they could understand71%
Nurses "always" listened carefully71%
Nurses "always" treated them with courtesy and respect83%
"Always" quiet at night52%
"YES", patients would definitely recommend the hospital80%
Staff "always" explained possible side effects48%
Yes, staff "did" give patients information about possible symptoms88%
See every measure and the patient survey for Community Regional Medical Center

Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Community Regional Medical Center
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths211.21 (174.88 to 247.54) · 239 casesWorseJul 2022 – Jun 2024
Clostridium Difficile (C.Diff)Infections0.705BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.13 (0.29 to 1.96) · 2,304 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.09 (0.87 to 1.3)No differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths3.2 · 187 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 116 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.7 · 187 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths10.6 · 445 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths15.2 · 399 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 582 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.2 · 3,744 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.31 (0.12 to 0.5) · 11,052 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.27 (0.1 to 0.45) · 11,566 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.33 (1.64 to 5.01) · 3,139 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.08 (0 to 2.3) · 1,423 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.7 (0.52 to 2.88) · 3,084 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths11.85 (8.11 to 15.6) · 1,481 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths6.4 (3.81 to 8.98) · 1,404 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths2.35 (0.95 to 3.76) · 760 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.64 (0.16 to 1.11) · 10,254 casesNo differentJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.817No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections1.031No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.837No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.81No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.853No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.8 · 258 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits22 · 689 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits37.4 · 202 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits35.2 · 543 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits39.2 · 434 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits19.3 · 552 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.4 (3.6 to 7.9) · 169 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits11.4 (8.3 to 15.4) · 169 casesNo differentJan 2024 – Dec 2024
Rate of readmission for CABGUnplanned return visits12.4 · 189 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits21.6 · 248 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits11.9 (9.5 to 14.9) · 2,590 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.7 to 1.2) · 310 casesNo differentJan 2024 – Dec 2024

What patients said (421 patients answered, 26% of those asked)

Patient survey stars by topic at Community Regional Medical Center
Cleanliness4
Nurse communication2
Doctor communication3
Communication about medicines2
Discharge information4
Overall hospital rating3
Quietness1
Recommend hospital3
Share of patients giving the best answer at Community Regional Medical Center
Room was "always" clean74%
Nurses "always" communicated well74%
Doctors "always" communicated well77%
Staff "always" explained55%
Yes, staff "did" give patients this information87%
Yes, staff "did" give patients information about help after discharge85%
Doctors "always" explained things so they could understand71%
Doctors "always" listened carefully76%
Doctors "always" treated them with courtesy and respect83%
Patients who gave a rating of "9" or "10" (high)66%
Staff "always" explained new medications69%
Nurses "always" explained things so they could understand70%
Nurses "always" listened carefully70%
Nurses "always" treated them with courtesy and respect82%
"Always" quiet at night43%
"YES", patients would definitely recommend the hospital70%
Staff "always" explained possible side effects41%
Yes, staff "did" give patients information about possible symptoms88%
See every measure and the patient survey for Saint Agnes Medical Center

Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Saint Agnes Medical Center
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.274BetterOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.312BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.141BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.18 to 1.94) · 2,342 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.02 (0.76 to 1.27)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths197.82 (152.64 to 243.01) · 103 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths3.9 · 105 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.3 · 300 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.9 · 295 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths10.8 · 768 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths15.8 · 969 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths11.2 · 304 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.7 · 4,305 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.24 (0.06 to 0.42) · 11,641 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.25 (0.07 to 0.43) · 12,213 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.76 (2.91 to 6.61) · 2,466 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.09 (0 to 2.49) · 864 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.61 (0.26 to 2.96) · 2,362 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths10.1 (5.39 to 14.81) · 900 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.4 (1.2 to 7.59) · 882 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.84 (0.41 to 3.27) · 541 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.67 (0.14 to 1.19) · 9,626 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.9 · 58 casesNoneApr 2023 – Mar 2025
MRSA BacteremiaInfections0.835No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections1.182No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.004No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.8 · 412 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits22.6 · 1,002 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits28.8 · 296 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits25.5 · 894 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits17.8 · 981 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.1 · 1,061 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits5 · 56 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits13.4 · 150 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.3 · 412 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.3 (9.6 to 15.9) · 1,324 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.7 to 1.1) · 863 casesNo differentJan 2024 – Dec 2024

What patients said (812 patients answered, 32% of those asked)

Patient survey stars by topic at Saint Agnes Medical Center
Cleanliness4
Nurse communication3
Doctor communication2
Communication about medicines3
Discharge information3
Overall hospital rating4
Quietness3
Recommend hospital4
Share of patients giving the best answer at Saint Agnes Medical Center
Room was "always" clean73%
Nurses "always" communicated well73%
Doctors "always" communicated well74%
Staff "always" explained61%
Yes, staff "did" give patients this information85%
Yes, staff "did" give patients information about help after discharge83%
Doctors "always" explained things so they could understand70%
Doctors "always" listened carefully73%
Doctors "always" treated them with courtesy and respect80%
Patients who gave a rating of "9" or "10" (high)71%
Staff "always" explained new medications75%
Nurses "always" explained things so they could understand68%
Nurses "always" listened carefully70%
Nurses "always" treated them with courtesy and respect80%
"Always" quiet at night50%
"YES", patients would definitely recommend the hospital76%
Staff "always" explained possible side effects47%
Yes, staff "did" give patients information about possible symptoms87%

Original Medicare doctor bills

$1,141,216

Medicare paid this office $1,141,216 for 1,736 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Nuclear medicine studies of blood flow in heart muscle at rest and with stress253$308,780$1,216
Return visit (30+ min)1,371$240,369$92
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries253$208,359$410
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function758$115,182$150
Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional149$104,968$695
See all 26 services
Every Original Medicare service billed
Nuclear medicine studies of blood flow in heart muscle at rest and with stress253$308,780$1,216
Return visit (30+ min)1,371$240,369$92
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries253$208,359$410
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function758$115,182$150
Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional149$104,968$695
New patient visit (45+ min)319$36,209$114
Short return visit (20+ min)276$19,540$68
Nuclear medicine studies of heart muscle at rest and with stress and spect57$18,974$333
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report1,422$18,446$11
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician308$17,909$57
Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days50$10,545$211
Injection, regadenoson, 0.1 mg295$7,169None
Initial hospital care with moderate level of medical decision making at least 75 minutes41$6,001$136
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes39$5,696$93
Technetium tc-99m sestamibi, diagnostic, per study dose56$3,972$35
Long return visit (40+ min)22$3,222$146
Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional150$2,925$19
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function55$2,709$49
Electrocardiogram (ecg) 2-day continuous with review and report by health care professional21$1,168$56
Ultrasound of heart with probe in esophagus, with report12$1,073$83
New patient visit (30+ min)11$904$82
Injection, aminophyllin, up to 250 mg45$310None
Ultrasound of heart, follow-up13$271$19
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only32$209$6
Ultrasound of heart blood flow, valves and chambers, follow-up11$61$6
Ultrasound of heart with color-depicted blood flow, rate and valve function18$48$2

Who their Medicare patients are

1,736 Original Medicare patients in 2024. Average age 75 · Under 65 5% · 85 and older 12% · Women 52% · Also on Medicaid 16% · Health risk score 1.24. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.

Conditions among them: High blood pressure 75% · Coronary heart disease 60% · Diabetes 36% · Chronic kidney disease 30% · Heart failure 29% · Atrial fibrillation 20% · Cancer 18% · Depression 17% · COPD 13% · Stroke 7% · Dementia 6%.

The office billed $4,920,305, Medicare allowed $1,497,498 and paid $1,141,216; for 8,968 services of 46 kinds; $7,496 of it was for drugs given in the office and $1,133,720 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20241,7368,968751.24$4,920,305$1,141,216
20231,5208,233751.14$4,612,685$1,144,901
20221,3007,309751.25$3,896,201$973,254
20211,1747,387741.34$3,899,631$1,117,732
20201,0886,104751.57$2,569,041$954,633
20199684,445741.48$972,766$417,394
20187603,683741.88$815,011$420,662
20177352,994752.19$656,556$306,034
20167122,461751.86$538,835$239,512
2015173644751.76$135,514$64,275

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 26 services

Original Medicare services billed in 2023
Nuclear medicine studies of blood flow in heart muscle at rest and with stress286$356,981$1,248
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries286$238,756$417
Return visit (30+ min)1,074$193,849$98
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function709$117,426$162
Injection, regadenoson, 0.1 mg327$57,479None
New patient visit (45+ min)334$39,241$117
Short return visit (20+ min)354$24,972$65
Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional29$21,290$734
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician334$19,506$58
Nuclear medicine studies of heart muscle at rest and with stress and spect50$19,015$380
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report1,179$15,308$11
Long return visit (40+ min)37$6,063$144
Initial hospital care with moderate level of medical decision making at least 75 minutes33$4,809$141
Telephone medical discussion with physician, 21-30 minutes32$3,645$104
Technetium tc-99m sestamibi, diagnostic, per study dose48$3,578$37
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes28$3,493$97
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function60$3,290$55
Telephone medical discussion with physician, 11-20 minutes41$2,845$66
Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days117$2,216$19
New patient visit (30+ min)18$1,308$73
Heart rhythm recording continous external ekg over more than 48 hours up to 7 days117$1,199$10
Ultrasound of heart with probe in esophagus, with report12$1,018$85
Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional29$600$21
Injection, aminophyllin, up to 250 mg48$359None
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only22$143$6
Ultrasound of heart with color-depicted blood flow, rate and valve function14$35$2

2022: 27 services

Original Medicare services billed in 2022
Nuclear medicine studies of blood flow in heart muscle at rest and with stress241$303,301$1,243
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries241$202,739$415
Return visit (30+ min)683$117,059$97
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function597$100,350$165
Injection, regadenoson, 0.1 mg266$52,611None
New patient visit (45+ min)337$43,006$128
Short return visit (20+ min)517$39,006$67
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician267$15,973$59
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report1,028$13,629$11
Telephone medical discussion with physician, 11-20 minutes175$13,555$67
Long return visit (40+ min)71$11,691$146
Nuclear medicine studies of heart muscle at rest and with stress and spect30$11,187$373
Telephone medical discussion with physician, 21-30 minutes92$10,146$102
Initial hospital care with moderate level of medical decision making at least 75 minutes57$9,488$161
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes35$5,150$83
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function84$4,747$57
Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days148$3,018$20
New patient visit (30+ min)29$2,455$85
New patient visit (60+ min)13$2,372$182
Technetium tc-99m sestamibi, diagnostic, per study dose29$2,225$38
Heart rhythm recording continous external ekg over more than 48 hours up to 7 days148$1,768$12
Ultrasound of heart with probe in esophagus, with report13$1,144$88
Telephone medical discussion with physician, 5-10 minutes18$844$47
Injection, aminophyllin, up to 250 mg46$346None
Ultrasound of heart, follow-up16$328$20
Ultrasound of heart blood flow, valves and chambers12$175$15
Ultrasound of heart with color-depicted blood flow, rate and valve function22$61$3

2021: 28 services

Original Medicare services billed in 2021
Nuclear medicine studies of blood flow in heart muscle at rest and with stress302$390,397$1,293
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries302$256,129$424
Return visit (30+ min)583$109,815$100
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function507$87,370$170
Injection, regadenoson, 0.1 mg332$63,490None
New patient visit (45+ min)289$36,740$127
Short return visit (20+ min)407$31,867$72
Telephone medical discussion with physician, 11-20 minutes256$23,275$75
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician336$20,135$60
Long return visit (40+ min)76$14,790$148
Nuclear medicine studies of heart muscle at rest and with stress and spect35$14,350$410
Initial hospital care with moderate level of medical decision making at least 75 minutes70$12,245$163
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report844$12,002$12
Telephone medical discussion with physician, 21-30 minutes68$8,548$107
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function112$6,431$57
Technetium tc-99m sestamibi, diagnostic, per study dose35$6,163$88
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes52$5,903$86
Telephone medical discussion with physician, 5-10 minutes49$2,682$47
Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days112$2,336$20
Ultrasound of heart with probe in esophagus, with report15$1,525$90
Heart rhythm recording continous external ekg over more than 48 hours up to 7 days112$1,439$13
New patient visit (30+ min)14$1,051$75
Injection, aminophyllin, up to 250 mg47$314None
Ultrasound of heart, follow-up14$314$21
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only39$286$7
Electrocardiogram (ecg) 1 to 3 leads with review by physician13$129$10
Ultrasound of heart blood flow, valves and chambers, follow-up12$77$6
Ultrasound of heart with color-depicted blood flow, rate and valve function24$76$3

2020: 24 services

Original Medicare services billed in 2020
Nuclear medicine studies of blood flow in heart muscle at rest and with stress278$366,219$1,313
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries279$234,200$419
Return visit (30+ min)622$85,749$86
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function439$77,902$171
Injection, regadenoson, 0.1 mg313$59,248None
New patient visit (45+ min)187$22,575$121
Short return visit (20+ min)345$22,476$56
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician315$18,940$59
Nuclear medicine studies of heart muscle at rest and with stress and spect40$14,235$356
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report705$10,389$13
Initial hospital care with moderate level of medical decision making at least 75 minutes54$9,208$164
Technetium tc-99m sestamibi, diagnostic, per study dose40$7,292$91
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function75$4,553$60
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes33$3,560$87
New patient visit (30+ min)40$3,413$85
External ekg recording for more than 48 hours up to 21 days89$2,048$23
Review and interpretation of external ekg recording for more than 48 hours up to 21 days89$2,016$22
Telephone medical discussion with physician, 11-20 minutes17$981$58
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only112$640$5
Ultrasound of heart, follow-up13$281$22
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic19$204$11
Injection, aminophyllin, up to 250 mg23$149None
Ultrasound of heart blood flow, valves and chambers, follow-up11$68$6
Ultrasound of heart with color-depicted blood flow, rate and valve function17$49$3

2019: 21 services

Original Medicare services billed in 2019
Nuclear medicine studies of blood flow in heart muscle at rest and with stress73$91,133$1,248
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function400$68,326$165
Short return visit (20+ min)584$40,721$55
Return visit (30+ min)312$39,377$84
Nuclear medicine studies of heart muscle at rest and with stress and spect75$30,654$409
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries73$29,870$205
New patient visit (45+ min)227$27,859$123
Injection, regadenoson, 0.1 mg144$26,074None
Technetium tc-99m sestamibi, diagnostic, per study dose76$14,461$95
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report766$11,703$13
Initial hospital care with moderate level of medical decision making at least 75 minutes52$8,820$163
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician146$8,115$56
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes33$3,582$83
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function37$2,302$61
Review and interpretation of external ekg recording for more than 48 hours up to 21 days74$1,634$22
External ekg recording for more than 48 hours up to 21 days74$1,378$18
Ultrasound of heart with probe in esophagus, with report11$994$90
Ultrasound of heart with color-depicted blood flow, rate and valve function11$240$22
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only16$119$7
Injection, aminophyllin, up to 250 mg11$71None
Ultrasound of heart with color-depicted blood flow, rate and valve function15$42$3

2018: 23 services

Original Medicare services billed in 2018
Nuclear medicine studies of blood flow in heart muscle at rest and with stress78$108,435$1,390
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function349$70,063$190
Return visit (30+ min)264$40,048$91
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries77$29,191$190
New patient visit (45+ min)203$26,727$132
Nuclear medicine studies of heart muscle at rest and with stress and spect56$25,758$460
Injection, regadenoson, 0.1 mg134$23,621None
Short return visit (20+ min)332$23,518$62
Initial hospital care with moderate level of medical decision making at least 75 minutes75$13,794$182
Technetium tc-99m sestamibi, diagnostic, per study dose56$11,943$107
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician138$8,742$63
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report447$7,813$14
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function115$6,543$57
Critical care, first 30-74 minutes20$6,069$202
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes55$5,218$66
Electrocardiogram (ecg) 2-day continuous with review by health care professional67$1,715$25
Electrocardiogram (ecg) 2-day continuous67$1,412$20
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes12$1,071$89
Review and interpretation of external ekg recording for more than 48 hours up to 21 days15$373$25
Ultrasound of heart, follow-up15$315$21
External ekg recording for more than 48 hours up to 21 days15$291$19
Ultrasound of heart blood flow, valves and chambers, follow-up14$84$6
Ultrasound of heart with color-depicted blood flow, rate and valve function19$50$3

2017: 24 services

Original Medicare services billed in 2017
Nuclear medicine studies of blood flow in heart muscle at rest and with stress65$75,050$1,155
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function243$45,919$187
Return visit (30+ min)235$29,435$83
Injection, regadenoson, 0.1 mg112$19,351None
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries64$18,744$146
Nuclear medicine studies of heart muscle at rest and with stress and spect46$18,552$403
New patient visit (45+ min)137$16,452$120
Initial hospital care with moderate level of medical decision making at least 75 minutes93$15,759$164
Short return visit (20+ min)174$10,524$56
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function192$9,683$50
Technetium tc-99m sestamibi, diagnostic, per study dose47$8,827$94
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes50$7,615$85
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician113$6,835$60
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report282$4,391$13
Critical care, first 30-74 minutes13$4,134$180
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes49$3,633$59
New patient visit (60+ min)16$2,410$151
Electrocardiogram (ecg) 2-day continuous with review by health care professional54$1,189$22
Electrocardiogram (ecg) 2-day continuous54$1,040$19
Ultrasound of heart with probe in esophagus, with report11$986$90
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only82$634$7
Ultrasound of heart, follow-up12$253$21
Ultrasound of heart with color-depicted blood flow, rate and valve function17$45$3
Infusion, normal saline solution , 1000 cc24$36None

2016: 20 services

Original Medicare services billed in 2016
Nuclear medicine studies of blood flow in heart muscle at rest and with stress37$42,925$1,160
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function223$42,569$188
Nuclear medicine studies of heart muscle at rest and with stress and spect53$21,643$408
New patient visit (45+ min)165$21,245$129
Short return visit (20+ min)219$15,447$58
Injection, regadenoson, 0.1 mg88$14,618None
Initial hospital care with moderate level of medical decision making at least 75 minutes85$14,507$161
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries37$11,470$155
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes71$10,550$84
Technetium tc-99m sestamibi, diagnostic, per study dose53$9,971$94
Return visit (30+ min)82$7,763$82
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function113$5,833$51
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician93$5,383$58
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report191$2,610$14
New patient visit (30+ min)25$2,076$83
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only164$1,184$7
Electrocardiogram (ecg) 2-day continuous with review by health care professional46$1,022$22
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes14$935$58
Electrocardiogram (ecg) 2-day continuous46$935$20
Infusion, normal saline solution , 1000 cc37$56None

2015: 12 services

Original Medicare services billed in 2015
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function51$10,087$190
New patient visit (45+ min)54$7,180$133
Return visit (30+ min)66$6,627$87
Initial hospital care with moderate level of medical decision making at least 75 minutes32$5,450$165
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes30$3,185$59
Injection, regadenoson, 0.1 mg17$3,032None
Short return visit (20+ min)23$1,500$60
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report81$1,141$14
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician17$1,067$59
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function17$937$52
Electrocardiogram (ecg) 2-day continuous with review by health care professional17$376$22
Electrocardiogram (ecg) 2-day continuous17$338$20

Medicaid work

$2,217 in 2024

Medicaid paid $2,217 for 445 billed services this clinician did in 2024, up to 36 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Return visit (30+ min)241$887
Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography26$817
Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report178$514
Medicaid work by year
2024445336$2,217
2023493431$1,426
202264314$325
202140215$144
202013113$9
2019186319$300
2018445529$6,871
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography66$754
Return visit (30+ min)222$371
Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report192$288
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only13$12

2022

Largest Medicaid services in 2022
Return visit (30+ min)26$248
Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report26$78
Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography12$0

2021

Largest Medicaid services in 2021
Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography28$118
Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report12$26

2020

Largest Medicaid services in 2020
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only13$9

2019

Largest Medicaid services in 2019
Short return visit (20+ min)51$197
Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report96$103
Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography39$0

2018

Largest Medicaid services in 2018
Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography94$2,379
New patient visit (45+ min)49$1,885
Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report201$1,504
OFF/OP CNSLTJ NEW/EST MOD 4015$977
Short return visit (20+ min)86$126

Drugs they prescribed that Part D paid

$1,203,564

Pharmacies billed $1,203,564 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 7,833) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.

6,759 generic and 1,074 brand-name prescriptions · $1,203,564 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Eliquis450$537,869$1,195
Entresto144$211,735$1,470
Xarelto110$138,916$1,263
Repatha Sureclick132$115,427$874
Jardiance20$32,080$1,604
See all 53 drugs
Every Part D drug this clinician prescribed
Eliquis450$537,869$1,195
Entresto144$211,735$1,470
Xarelto110$138,916$1,263
Repatha Sureclick132$115,427$874
Jardiance20$32,080$1,604
Farxiga12$18,193$1,516
Metoprolol1,102$17,193$16
Rosuvastatin500$7,783$16
Praluent16$7,628$477
Flecainide Acetate136$7,127$52
Bumetanide94$6,754$72
Amiodarone107$6,308$59
Losartan633$6,014$10
Potassium Chloride184$5,443$30
Carvedilol542$4,920$9
Atorvastatin474$4,791$10
Amlodipine Besylate607$4,625$8
Hydralazine255$4,450$17
Diltiazem 24hr Er (La)39$4,393$113
Icosapent Ethyl13$4,158$320
Ezetimibe94$4,017$43
Nitroglycerin306$3,170$10
Nifedipine Er61$2,100$34
Midodrine25$2,070$83
Isosorbide Mononitrate Er153$1,931$13
Lisinopril210$1,913$9
Propafenone18$1,878$104
Spironolactone190$1,845$10
Clopidogrel121$1,824$15
Furosemide197$1,114$6
Olmesartan Medoxomil15$950$63
Valsartan39$847$22
Diltiazem28$807$29
Chlorthalidone51$787$15
Metoprolol101$762$8
Diltiazem 24hr Er (Cd)36$731$20
Doxazosin Mesylate34$634$19
Cartia Xt18$614$34
Klor-Con 1018$524$29
Benazepril32$440$14
Propranolol15$439$29
Irbesartan32$402$13
Diltiazem 24hr Er13$377$29
Hydrochlorothiazide63$371$6
Losartan-Hydrochlorothiazide21$357$17
Pravastatin22$353$16
Lisinopril-Hydrochlorothiazide12$351$29
Bisoprolol15$350$23
Warfarin44$275$6
Simvastatin23$206$9
Clonidine15$192$13
Atenolol41$147$4
Amlodipine Besylate-Benazepril11$121$11

Year by year

Part D prescribing by year
20247,8331,3580% (0)14%$1,203,564
20235,8421,0220% (0)14%$770,980
20225,5898500% (0)12%$585,078
20214,8817240% (0)13%$458,336
20203,685612None14%$345,427
20193,227483None14%$242,716
20182,551345None17%$170,961
20171,321203None29%$95,851
2016635114None28%$43,011
2015117380% (0)21%$4,979
201419748None12%$9,010
201314254None32%$9,698

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 41 drugs

Part D drugs prescribed in 2023
Eliquis341$334,138$980
Entresto106$144,019$1,359
Xarelto85$103,898$1,222
Repatha Sureclick37$39,802$1,076
Metoprolol937$19,425$21
Farxiga14$12,369$884
Amiodarone99$9,289$94
Rosuvastatin307$8,245$27
Atorvastatin409$7,730$19
Carvedilol445$6,439$14
Potassium Chloride228$5,752$25
Losartan376$5,150$14
Flecainide Acetate88$5,147$58
Bumetanide73$4,241$58
Amlodipine Besylate364$3,905$11
Nitroglycerin265$3,824$14
Ezetimibe67$2,901$43
Hydralazine147$2,682$18
Lisinopril181$2,590$14
Isosorbide Mononitrate Er127$2,347$18
Midodrine31$2,307$74
Diltiazem 24hr Er (La)17$2,199$129
Furosemide220$1,644$7
Spironolactone140$1,596$11
Clopidogrel77$1,583$21
Chlorthalidone39$1,322$34
Diltiazem24$1,132$47
Diltiazem 24hr Er (Cd)38$1,112$29
Metoprolol99$1,104$11
Nifedipine Er15$804$54
Klor-Con 1026$777$30
Valsartan22$717$33
Diltiazem 24hr Er (Xr)12$695$58
Diltiazem 24hr Er20$525$26
Irbesartan13$506$39
Cartia Xt15$497$33
Simvastatin14$364$26
Hydrochlorothiazide53$307$6
Doxazosin Mesylate13$300$23
Atenolol35$286$8
Warfarin21$231$11

2022: 42 drugs

Part D drugs prescribed in 2022
Eliquis311$246,956$794
Entresto98$105,409$1,076
Xarelto76$75,432$993
Repatha Sureclick30$35,761$1,192
Metoprolol1,050$19,867$19
Amiodarone57$7,463$131
Rosuvastatin228$6,851$30
Atorvastatin436$6,185$14
Pradaxa11$5,954$541
Flecainide Acetate93$5,631$61
Carvedilol373$4,694$13
Nitroglycerin296$4,617$16
Losartan344$3,906$11
Potassium Chloride147$3,692$25
Hydralazine172$3,137$18
Bumetanide76$3,071$40
Ezetimibe62$3,058$49
Isosorbide Mononitrate Er175$2,431$14
Diltiazem 24hr Er (Cd)53$2,128$40
Amlodipine Besylate295$1,973$7
Chlorthalidone53$1,749$33
Lisinopril146$1,722$12
Spironolactone156$1,681$11
Clopidogrel91$1,190$13
Furosemide156$1,002$6
Diltiazem33$987$30
Nifedipine Er16$758$47
Valsartan20$697$35
Diltiazem 24hr Er (Xr)20$574$29
Diltiazem 24hr Er14$509$36
Metoprolol52$501$10
Cartia Xt14$446$32
Klor-Con 1017$443$26
Simvastatin24$425$18
Doxazosin Mesylate14$414$30
Bisoprolol11$348$32
Warfarin26$300$12
Hydrochlorothiazide42$279$7
Atenolol33$226$7
Clonidine14$208$15
Lisinopril-Hydrochlorothiazide13$125$10
Alprazolam13$14$1

2021: 43 drugs

Part D drugs prescribed in 2021
Eliquis267$190,455$713
Entresto83$75,438$909
Xarelto36$43,343$1,204
Metoprolol883$19,200$22
Repatha Sureclick27$19,080$707
Rosuvastatin256$9,605$38
Amiodarone51$6,995$137
Pradaxa13$6,323$486
Atorvastatin387$6,186$16
Nitroglycerin288$4,482$16
Bystolic12$4,299$358
Flecainide Acetate56$4,123$74
Losartan282$3,970$14
Bumetanide110$3,879$35
Carvedilol364$3,724$10
Cardizem La13$3,150$242
Pacerone23$2,755$120
Hydralazine192$2,735$14
Diltiazem 24hr Er (Cd)65$2,599$40
Potassium Chloride89$2,425$27
Ezetimibe31$2,326$75
Prasugrel11$2,026$184
Spironolactone161$1,816$11
Valsartan35$1,704$49
Isosorbide Mononitrate Er122$1,695$14
Amlodipine Besylate203$1,588$8
Clopidogrel78$1,466$19
Diltiazem 24hr Er28$1,069$38
Midodrine16$1,068$67
Chlorthalidone43$1,023$24
Lisinopril122$969$8
Cartia Xt17$863$51
Furosemide114$650$6
Metoprolol41$496$12
Nifedipine Er18$476$26
Warfarin32$469$15
Atenolol25$404$16
Diltiazem12$364$30
Clonidine14$293$21
Benazepril11$274$25
Simvastatin17$208$12
Hydrochlorothiazide31$183$6
Lisinopril-Hydrochlorothiazide23$90$4

2020: 44 drugs

Part D drugs prescribed in 2020
Eliquis189$147,921$783
Entresto58$48,960$844
Xarelto38$41,837$1,101
Metoprolol769$18,933$25
Repatha Sureclick16$11,039$690
Brilinta17$7,658$450
Atorvastatin339$5,496$16
Rosuvastatin96$4,637$48
Nitroglycerin219$3,720$17
Benicar Hct11$2,702$246
Losartan190$2,533$13
Bumetanide79$2,443$31
Flecainide Acetate27$2,346$87
Bystolic12$2,220$185
Carvedilol204$1,989$10
Prasugrel11$1,959$178
Diltiazem 24hr Er (Cd)60$1,768$29
Hydralazine80$1,640$20
Diltiazem 24hr Er31$1,393$45
Spironolactone133$1,341$10
Midodrine23$1,219$53
Ezetimibe23$1,146$50
Valsartan18$1,076$60
Amlodipine Besylate164$1,052$6
Isosorbide Mononitrate Er68$1,005$15
Clopidogrel46$915$20
Potassium Chloride34$903$27
Amiodarone35$889$25
Lisinopril111$810$7
Cartia Xt34$784$23
Chlorthalidone23$731$32
Irbesartan-Hydrochlorothiazide14$682$49
Metoprolol79$620$8
Furosemide82$582$7
Dilt-Xr13$565$43
Verapamil Er20$505$25
Nifedipine Er11$502$46
Warfarin36$443$12
Hydrochlorothiazide28$212$8
Clonidine11$201$18
Pravastatin15$162$11
Simvastatin16$146$9
Lisinopril-Hydrochlorothiazide22$128$6
Alprazolam15$20$1

2019: 32 drugs

Part D drugs prescribed in 2019
Eliquis163$110,235$676
Xarelto41$30,288$739
Entresto21$20,500$976
Metoprolol624$18,143$29
Atorvastatin306$5,077$17
Amiodarone57$3,079$54
Nitroglycerin162$2,654$16
Bumetanide49$2,506$51
Carvedilol192$2,072$11
Rosuvastatin27$1,995$74
Losartan124$1,560$13
Spironolactone173$1,472$9
Chlorthalidone46$1,422$31
Diltiazem 24hr Er (Cd)45$1,306$29
Lisinopril184$1,263$7
Isosorbide Mononitrate Er100$1,111$11
Amlodipine Besylate155$1,064$7
Ezetimibe25$1,054$42
Hydralazine53$927$17
Valsartan11$798$73
Cartia Xt34$739$22
Diltiazem 24hr Er19$704$37
Dilt-Xr22$592$27
Furosemide104$575$6
Diltiazem11$525$48
Potassium Chloride21$501$24
Metoprolol66$449$7
Clopidogrel39$394$10
Warfarin34$320$9
Bisoprolol12$233$19
Simvastatin17$135$8
Hydrochlorothiazide27$117$4

2018: 32 drugs

Part D drugs prescribed in 2018
Eliquis127$75,615$595
Xarelto25$21,232$849
Metoprolol438$12,140$28
Entresto19$9,827$517
Atorvastatin255$3,512$14
Nitroglycerin94$1,796$19
Carvedilol201$1,464$7
Spironolactone152$1,447$10
Ezetimibe11$1,393$127
Valsartan28$1,348$48
Chlorthalidone48$1,258$26
Isosorbide Mononitrate Er93$1,233$13
Amiodarone50$1,027$21
Lisinopril160$1,016$6
Losartan92$764$8
Diltiazem 24hr Er (Cd)38$754$20
Cartia Xt28$688$25
Diltiazem26$667$26
Rosuvastatin24$651$27
Dilt-Xr20$505$25
Metoprolol67$473$7
Furosemide108$455$4
Amlodipine Besylate84$408$5
Hydralazine32$405$13
Enalapril Maleate12$372$31
Nitroglycerin Patch14$338$24
Clopidogrel43$333$8
Warfarin22$211$10
Potassium Chloride12$202$17
Simvastatin18$168$9
Klor-Con M2013$159$12
Hydrochlorothiazide18$71$4

2017: 23 drugs

Part D drugs prescribed in 2017
Eliquis123$57,598$468
Xarelto16$8,228$514
Metoprolol270$5,208$19
Livalo12$2,973$248
Atorvastatin141$1,696$12
Nitroglycerin44$1,053$24
Chlorthalidone29$927$32
Rosuvastatin20$884$44
Carvedilol78$551$7
Spironolactone81$542$7
Nitroglycerin Patch12$466$39
Isosorbide Mononitrate Er43$463$11
Lisinopril78$452$6
Diltiazem 24hr Er23$434$19
Enalapril Maleate12$425$35
Clopidogrel33$306$9
Cartia Xt22$291$13
Losartan42$188$4
Amlodipine Besylate49$173$4
Simvastatin13$86$7
Metoprolol17$82$5
Clonidine15$71$5
Furosemide23$45$2

2016: 15 drugs

Part D drugs prescribed in 2016
Eliquis63$24,790$393
Metoprolol109$2,016$18
Atorvastatin48$696$15
Chlorthalidone24$684$29
Nitroglycerin Patch11$378$34
Diltiazem 24hr Er23$338$15
Carvedilol39$249$6
Amiodarone12$228$19
Lisinopril39$192$5
Spironolactone40$178$4
Furosemide36$103$3
Amlodipine Besylate29$82$3
Losartan11$60$5
Clopidogrel12$57$5
Metoprolol15$44$3

2015: 3 drugs

Part D drugs prescribed in 2015
Atorvastatin11$119$11
Metoprolol11$95$9
Lisinopril14$60$4

2014: 8 drugs

Part D drugs prescribed in 2014
Metoprolol16$796$50
Clopidogrel29$651$22
Atorvastatin14$399$28
Losartan13$229$18
Isosorbide Mononitrate Er12$168$14
Carvedilol20$161$8
Metoprolol15$118$8
Amlodipine Besylate11$77$7

2013: 4 drugs

Part D drugs prescribed in 2013
Atorvastatin15$517$34
Metoprolol11$473$43
Isosorbide Mononitrate Er12$260$22
Metoprolol14$125$9

Money from drug and device companies

$32 in 2023

Industry payments by year
202312None$32
202222None$163
202111None$129
2019419None$530

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
PfizerEliquis$32
2 payments
  • Meals for Eliquis · 2023-11-13 · $18
  • Meals for Eliquis · 2023-07-06 · $13
See all 2 published payments
Every published payment
PfizerMeals · 2023-11-13Eliquis$18
PfizerMeals · 2023-07-06Eliquis$13
See earlier years (2022, 2021, 2019)

2022: $163

Payments by company in 2022
Abbott LaboratoriesMitraclip$143
1 payment
  • Meals for Mitraclip · 2022-12-13 · $143
E.R. Squibb & Sons L.L.C.Camzyos$20
1 payment
  • Meals for Camzyos · 2022-10-24 · $20

2021: $129

Payments by company in 2021
Abbott LaboratoriesMitraclip System$129
1 payment
  • Meals for Mitraclip System · 2021-08-23 · $129

2019: $530

Payments by company in 2019
AmgenRepatha$260
14 payments
  • Meals for Repatha · 2019-10-17 · $32
  • Meals for Repatha · 2019-09-06 · $21
  • Meals for Repatha · 2019-09-04 · $17
  • Meals for Repatha · 2019-06-11 · $18
  • Meals for Repatha · 2019-05-14 · $10
  • Meals for Repatha · 2019-05-14 · $12
  • Meals for Corlanor · 2019-05-09 · $14
  • Meals for Repatha · 2019-04-25 · $22
  • Meals for Corlanor · 2019-03-28 · $17
  • Meals for Corlanor · 2019-03-21 · $14
  • Meals for Corlanor · 2019-03-14 · $27
  • Meals for Repatha · 2019-03-06 · $8
  • Meals for Repatha · 2019-02-06 · $28
  • Meals for Repatha · 2019-01-18 · $21
Abbott LaboratoriesHeartmate 3 Left Ventricular Dev$140
1 payment
  • Meals for Heartmate 3 Left Ventricular Dev · 2019-12-09 · $140
Medtronic VascularArctic Front$88
1 payment
  • Meals for Arctic Front · 2019-10-09 · $88
Novartis PharmaceuticalsEntresto$41
3 payments
  • Meals for Entresto · 2019-12-18 · $16
  • Meals for Entresto · 2019-07-17 · $14
  • Meals for Entresto · 2019-03-07 · $12

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
85.8 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1720283393
Licence
CA 11348, TX BP1-0026266, TX N6161, WI 57394-21California G11348: CancelledTexas N6161: Canc Non-RenewalTexas BP10026266: Permit Terminated
Group
Community Foundation Medical Group · Fresno Community Hospital and Medical Center
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Cardiology (207RC0000X); Internal medicine (207R00000X)
Mailing address
1313 E Herndon Ave Ste 203, Fresno, CA, 93720
NPI first listed
2007-06-15
NPI last updated
2015-08-10

This is when the NPI record was last certified, not a medical board exam.